课题基金 / 基金详情

Application of an ER chaperone inducer for Alzheimer disease

Application of an ER chaperone inducer for Alzheimer disease
ER伴侣诱导剂在阿尔茨海默病中的应用
批准号:
20591403
负责人:
KUDO Takashi
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

KUDO Takashi的其他基金

相似基金

相关文献

中文摘要
翻译
内质网(ER)应激反应是一种防御系统,用于处理内质网腔内未折叠蛋白的积累。近年来的研究表明,内质网应激参与了一些神经退行性疾病和脑缺血的病理过程。在筛选诱导ER介导的伴侣蛋白BiP/GRP 78(BiP)的化合物时,我们鉴定了BiP诱导剂X(BIX)。BIX优先诱导BiP,轻微诱导GRP 94、钙网蛋白和CHOP。BIX对BiP mRNA的诱导是通过激活BiP基因上游的ER应激反应元件(ERSE)介导的,通过ATF 6途径。用BIX预处理神经母细胞瘤细胞减少了由ER应激诱导的细胞死亡。脑室内预处理BIX可减少小鼠局灶性脑缺血引起的梗死面积。在BIX处理小鼠的半影区,ER应激诱导的细胞凋亡被抑制,导致凋亡细胞数量减少。综合考虑这些结果,BIX似乎诱导BiP防止由ER应激引起的神经元死亡,这表明它可能是由ER应激引起的脑疾病的潜在治疗剂。
英文摘要
The endoplasmic reticulum (ER) stress response is a defense system for dealing with the accumulation of unfolded proteins in the ER lumen. Recent reports have shown that ER stress is involved in the pathology of some neurodegenerative diseases and cerebral ischemia. In a screen for compounds that induce the ER-mediated chaperone BiP/GRP78 (BiP), we identified BiP inducer X (BIX). BIX preferentially induced BiP with slight inductions of GRP94, calreticulin, and CHOP. The induction of BiP mRNA by BIX was mediated by activation of ER stress response elements (ERSEs) upstream of the BiP gene, through the ATF6 pathway. Pretreatment of neuroblastoma cells with BIX reduced cell death induced by ER stress. Intracerebroventricular pretreatment with BIX reduced the area of infarction due to focal cerebral ischemia in mice. In the penumbra of BIX-treated mice, ER stress-induced apoptosis was suppressed, leading to a reduction in the number of apoptotic cells. Considering these results together, it appears that BIX induces BiP to prevent neuronal death by ER stress, suggesting that it may be a potential therapeutic agent for cerebral diseases caused by ER stress.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Therapeutic strategy for Alzheimer disease by amolecular chaperone inducer
分子伴侣诱导剂治疗阿尔茨海默病的新策略
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [T. Kudo, K. Imaizumi, H. Hara, T. Tabira, M. Takeda]
通讯作者: M. Takeda
アミロイド・カスケード仮説を基に認知症は治るか?-認知症治療法開発の新機軸
基于淀粉样蛋白级联假说,痴呆症可以治愈吗?——痴呆症治疗发展的新突破
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Matsumoto K, Tsuchiya KJ, Ritvo ER, Tsujii M., 工藤喬]
通讯作者: 工藤喬
アルツハイマー病-基礎研究から予防・治療の新しいパラダイム-
阿尔茨海默病——基础研究预防和治疗新范式——
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [岩田, ら]
通讯作者: ら
DOI: 10.1038/sj.cdd.4402276
发表时间: 2008-02-01
期刊: CELL DEATH AND DIFFERENTIATION
影响因子: 12.4
作者: [Kudo, T., Kanemoto, S., Takeda, M.]
通讯作者: Takeda, M.
共 21 条
    Development of advanced but economical nuclear cardiology diagnostic procedure without using expensive equipment
    • 批准号:
      17K10447
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2017
    • 负责人:
      KUDO Takashi
    • 依托单位:
    Development of patient specific medicine using FDG PET and gene expression
    • 批准号:
      26461857
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2014
    • 负责人:
      KUDO Takashi
    • 依托单位:
    Loss of hematopoietic mucin-type O-glycan causes thrombocytopenia in mice
    • 批准号:
      24300152
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.32万
    • 财政年份:
      2012
    • 负责人:
      KUDO Takashi
    • 依托单位:
    Pathogenesis of tauopathies in terms of protein quality control mechanism
    • 批准号:
      24591709
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      KUDO Takashi
    • 依托单位:
    海外基金